Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Longitudinal evaluation of SARS-CoV-2 T cell immunity over 2 years following vaccination and infection.
J Infect Dis. 2024 Apr 30:jiae215. doi: 10.1093/infdis/jiae215. Online ahead of print.
J Infect Dis. 2024.
PMID: 38687181
Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE).
Bannister WP, Raben D, Valentiner-Branth P, Tolstrup M, Larsen L, Tarp B, Brouw Iversen M, Schmeltz Søgaard O, Rye Ostrowski S, Breinholt Stærke N, Jakobsen ML, Olaf Lindvig S, Ruwald Juhl M, Somuncu Johansen I, Mustafa AB, Østergaard L, Dam Larsen F, Surland Knudsen L, Klastrup V, Wiese L, Benfield T, Toft Petersen K, Iversen KK, Nielsen H, Reekie J, Lundgren J; ENFORCE Study Group.
Bannister WP, et al. Among authors: breinholt staerke n.
Open Forum Infect Dis. 2023 May 8;10(6):ofad248. doi: 10.1093/ofid/ofad248. eCollection 2023 Jun.
Open Forum Infect Dis. 2023.
PMID: 37351453
Free PMC article.
Item in Clipboard
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial.
Knuf M, Rämet M, Breinholt Stærke N, Bertrand-Gerentes I, Thollot Y, B'Chir S, Arroum H, Oster P.
Knuf M, et al. Among authors: breinholt staerke n.
Hum Vaccin Immunother. 2022 Nov 30;18(5):2052657. doi: 10.1080/21645515.2022.2052657. Epub 2022 Apr 21.
Hum Vaccin Immunother. 2022.
PMID: 35445641
Free PMC article.
Clinical Trial.
Item in Clipboard
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
ACTIV-3/TICO LY-CoV555 Study Group; Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, Østergaard L, Chang CC, Davey VJ, Goodman A, Higgs ES, Murray DD, Murray TA, Paredes R, Parmar MKB, Phillips AN, Reilly C, Sharma S, Dewar RL, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD.
ACTIV-3/TICO LY-CoV555 Study Group, et al.
N Engl J Med. 2021 Mar 11;384(10):905-914. doi: 10.1056/NEJMoa2033130. Epub 2020 Dec 22.
N Engl J Med. 2021.
PMID: 33356051
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite